Research paperEffect of AGOMELATINE (cas 138112-76-2) 25–50 mg on functional outcomes in patients with major depressive disorder
-
Add time:08/22/2019 Source:sciencedirect.com
PurposeThe purpose of this work is to investigate the effect of AGOMELATINE (cas 138112-76-2) on functioning compared with placebo in patients suffering from Major Depressive Disorder (MDD).
We also recommend Trading Suppliers and Manufacturers of AGOMELATINE (cas 138112-76-2). Pls Click Website Link as below: cas 138112-76-2 suppliers
Prev:Spike–Wave Discharges and Sleep–Wake States during Circadian Desynchronization: No Effects of AGOMELATINE (cas 138112-76-2) upon Re-Entrainment
Next:Behavioural pharmacologyStudies on the reproductive effects of chronic treatment with AGOMELATINE (cas 138112-76-2) in the rat) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- AGOMELATINE (cas 138112-76-2) treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light08/25/2019
- Mucoadhesive olaminosomes: A novel prolonged release nanocarrier of AGOMELATINE (cas 138112-76-2) for the treatment of ocular hypertension08/24/2019
- Behavioural pharmacologyStudies on the reproductive effects of chronic treatment with AGOMELATINE (cas 138112-76-2) in the rat08/23/2019
- Spike–Wave Discharges and Sleep–Wake States during Circadian Desynchronization: No Effects of AGOMELATINE (cas 138112-76-2) upon Re-Entrainment08/21/2019
- AGOMELATINE (cas 138112-76-2)-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus08/20/2019
- Oxymatrine ameliorates AGOMELATINE (cas 138112-76-2)-induced hepatocyte injury through promoting proteasome-mediated CHOP degradation08/19/2019
- Effects of AGOMELATINE (cas 138112-76-2) on electrocorticogram activity on penicillin-induced seizure model of rats08/18/2019
- Selective crystallization of AGOMELATINE (cas 138112-76-2) from molten state induced by polymer08/17/2019
- Research articleEffects of AGOMELATINE (cas 138112-76-2) in rotenone-induced Parkinson’s disease in rats08/16/2019